Dr. Wiseman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Mayo Clinic, Dept Nuc Med
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- University of WashingtonResidency, Nuclear Medicine, 1989 - 1992
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1987 - 1989
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1983 - 1985
- University of Utah School of MedicineClass of 1983
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- IA State Medical License 2013 - 2026
- AZ State Medical License 2013 - 2025
- MN State Medical License 1992 - 2025
- WI State Medical License 2014 - 2025
- FL State Medical License 2013 - 2022
- GA State Medical License 2013 - 2016
- WA State Medical License 1990 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, ...Chonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, Stephen Ansell, Andrew L Feldman
Leukemia & Lymphoma. 2024-03-01 - 8 citationsReal World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Ly...Muhamad Alhaj Moustafa, Jennifer Peterson, Bradford S Hoppe, Jennifer Jiang, Gregory A Wiseman
Clinical Lymphoma, Myeloma & Leukemia. 2022-08-01 - 2 citationsIbritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma.Sanjal Desai, Muhamad Alhaj Moustafa, Gregory A. Wiseman, Thomas E. Witzig
The Oncologist. 2021-07-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: